Israel, May 13, 2020 – CTech’s list of the country’s 50 most promising startups included Binah.ai as a company, which will survive and thrive despite coronavirus turmoil.
Every April Calcalist and CTech publish their list of the 50 most promising Israeli startups. This year, compiling the list was more difficult since the world economy, and the tech sector as part of it is still in the midst of the global coronavirus (Covid-19) pandemic. On one hand, companies that looked on a sure path to an exit back in January, now face extinction because their industry collapsed. On the other hand, the pandemic, with its health, economic and social fallout can provide an opportunity for companies in the startup nation that enjoys unparalleled innovative and entrepreneurial resources, backed by hefty investment opportunities.
After consulting with a wide range of industry experts, a member of the Prytek Group Binah.ai was chosen to be highlighted as a company that managed to push through and succeed despite the difficult circumstances, while doing the best to avoid hurting their workforce in the process.
David Maman – Founder and CEO of Binah.ai
Binah.ai in Post-Pandemic World
Israel-based start-up Binah’s CEO David Maman predicts the demand for vital sign monitoring technology will continue its acceleration into hospitals and health systems. But it will also reach into other areas of public life such as airports, food manufacturing plants, offices and other workplaces to thwart the ongoing threat of coronavirus.
“This is the next generation of business continuity, making sure that the health of the workforce is not being infected,” Maman told Medtech Insight.
Binah.ai’s plethysmography technology is used to detect slight changes in facial coloring to measure vital signs – heart rate, oxygen saturation, respiratory rate, stress level and heart rate variability – within seconds or minutes simply by scanning one’s cheeks with a camera. The company’s business model calls for software development kit companies to embed its technology into their platform.
Maman said his focus is to bring the technology into the health care space. Telemedicine has long been held back by regulatory restrictions in Europe and the US, but the threat of COVID-19 has led to a regulatory pull-back by various governments. This has opened the floodgates for telemedicine companies, and like many others in this space, Binah.ai is also now racing to gain permission from regulators in Europe, Canada and the US to bring their technology to market.